Botulinum Toxin A For Axillary Hyperhidrosis (Excessive Sweating)
NEJM 344:488-493, Heckmann,M.,et al, 2001
Fomepizole for the Treatment of Methanol Poinsoning
NEJM 344:424-429, Brent,J.,et al, 2001
Headache and CNS White Matter Abnormalities Associated with Gluten Sensitivity
Neurol 56:385-388, Hadjivassiliou,M.,et al, 2001
Low Back Pain
NEJM 344:363-370, Deyo,R.A. &Weinstein,J.N., 2001
Anticipation of Epileptic Seizures from Standard EEG Recordings
Lancet 357:183-188,160, Le Van Quyen,M.,et al, 2001
Neuro-Ophthalmic Manifestations of Sarcoidosis. Clincal Spectrum, Evaluation and Management
J Neuroophthalmol 21:132-137, Frohman,L.P,et al, 2001
The Benefit of an Acute Stroke Unit in Patients With Intracranial Haemorrahge: A Controlled Trial
JNNP 70:631-634, Ronning,O.M.,et al, 2001
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Hormone Replacement Therapy and Reduced Cognitive Decline in Older Women
Neurol 57:2210-2216, Carlson,M.C.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Ethical Considerations for Neurologist in the Management of Chronic Pain
Neurol 57:2166-2167, American academy of Neurology Ethics, Law and Huma, 2001
High-dose Intravenous Immune Globulin for Stiff-person Syndrome
NEJM 345:1870-1876, Dalakas,M.B.,et al, 2001
Rate of Spontaneous Resolution of a Solitary Cysticercus Granuloma in Patients With Seizures
Neurol 57:2315-2317, Rajshekhar,V., 2001
Botulinum Toxin as a Biological Weapon
JAMA 285:1059-1070, Arnon,S.S.,et al, 2001
A Case of Sleeping and Forgetting
Lancet 357:524, Corridan,B.J.,et al, 2001
Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001
Intramedullary High Signal Intensity on T2-Weighted MR Images in Cervical Spondylotic Myelopathy: Prediction of Prognosis with Type of Intensity
Radiology 221:789-794, Chen,C.,et al, 2001
Aptiganel Hydrochloride in Acute Ischemic Stroke
JAMA 286:2673-2682,2718, Albers,G.W.,et al, 2001
Oral Triptans (serotonin 5-HT 1B/1D agnosists) in Acute Migraine Treatment: A Meta-analysis of 53 Trials
Lancet 358:1668-1675, Ferrari,M.D.,et al, 2001
Surgical Therapy for Tremor in Multiple Sclerosis
Neurol 57:1876-1882, Matsumoto,J.,et al, 2001
Optical Filters Inhibiting Television-induced Photosensitive Seizures
Neurol 57:1767-1773,1747, Takahashi,Y.,et al, 2001
Randomized Controlled Trial of Zonisamide for the Treatment of Refractory Partial-onset Seizures
Neurol 57:1774-1779, Faught,E.,et al, 2001
Hyperperfusion-induced Intracerebral Hemorrhage After Carotid Stenting Documented by TCD
Neurol 57:1933-1935, Pfefferkorn,T.,et al, 2001
The Efficacy of Epidural Blood Patch in Spontaneous CSF Leaks
Neurol 57:1921-1923, Sencakova,D.,et al, 2001
Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001
Evidence Based Management of Attention Deficit Hyperactivity Disorder
BMJ 323:1232-1235, Guevara,J.P. &Stein,M.T., 2001
Seizures in Multiple Sclerosis
Epilepsia 42:72-79, Sokic,D.V.,et al, 2001
Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001
Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001
Management of Chronic Tension-Type Headache with Tricyclic Antidepressant Medication, Stress Management Therapy, and Their Combination
JAMA 285:2208-2215, Holroyd,K.A.,et al, 2001
A Blind Panic
Lancet 357:1262, Ayuk,J.,et al, 2001
Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001
Carotid Endarterectomy
The Neurologist 7:135-136, Stewart-Amidei,C., 2001
Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001
Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke 32:1061-1068, Claiborne Johnston,S.,et al, 2001
Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001
Viability Thresholds of Ischemic Penumbra of Hyperacute Stroke Defined by Perfusion-Weighted MRI and Apparent Diffusion Coefficient
Stroke 32:1140-1146, Rohl,L.,et al, 2001
Hypertensive Caudate Hemorrhage Prognostic Predictor, Outcome, and Role of External Ventricular Drainage
Stroke 32:1195-1200, Lilian,P.,et al, 2001
Initial and Follow-up MR Imaging Findings in AIDS-Related Progressive Multifocal Leukoencephalopathy Treated with Highly Active Antiretroviral Therapy
AJNR 22:977-984, Thurnher,M.M.,et al, 2001
Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001
Tinzaparin in Acute Ischaemic Stroke (TAIST):A Randomised Aspirin-Controlled Trial
Lancet 358:702-710,683, Bath,P.M.W.,et al, 2001
Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001
Oxcarbazepine (Trileptal) as Monotherapy in Patients with Partial Seizures
Neurol 57:864-871, Sachdeo,R.,et al, 2001
Long-Term Follow-Up of Neurosarcoidosis
Neurol 57:927-929, Ferriby,D.,et al, 2001
New Imaging Strategies for Patient Selection for Thrombolytic and Neuroprotective Therapies
Neurol 57:S48-S52, Warach,S., 2001
Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001
What Matters is Not the Differences Between Triptans, but the Differences Between Patients
Arch Neurol 58:1481-1482, Saper,J.R., 2001
Triptans Are All Different
Arch Neurol 58:1479-1480,1482, Rapoport,A.M.&Tepper,S.J., 2001
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001